The World Market for Cancer Diagnostics, 5th Edition: Precision and...
NEW YORK, June 6, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: The World Market for Cancer Diagnostics, 5th Edition: Precision and...
View ArticleCaris Life Sciences ASCO Presentation Highlights the Utility of Molecular...
Analysis of world's largest commercial cancer patient database uncovers clinically actionable targets IRVING, Texas, June 2, 2013 /PRNewswire/ -- Caris Life Sciences™, a leading biosciences company...
View ArticleRosetta Genomics Announces Acceptance for Publication by Molecular Cancer of...
(Source: Rosetta Genomics Ltd) PHILADELPHIAand REHOVOT, Israel, June 6, 2013/PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular...
View ArticleGround-breaking Research Identifies Molecular Subtyping as a Key to...
IRVINE, Calif., May 31, 2013 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that results from five studies focused on breast, colon and colorectal cancer will...
View ArticleRosetta Genomics Announces Acceptance for Publication by Molecular Cancer of...
PHILADELPHIA and REHOVOT, Israel, June 6, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that a manuscript...
View ArticleWest Clinic Researchers Present Findings at 2013 American Society for...
MEMPHIS, Tenn., May 31, 2013 /PRNewswire-USNewswire/ -- The West Clinic, the Mid-South's premier cancer center and world-class center of excellence in medical oncology, hematology, oncologic imaging,...
View ArticleGenomic Health Announces Ten Studies Covering Breast, Colon and Prostate...
REDWOOD CITY, Calif., May 21, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from ten studies in breast, colon and prostate cancer, including a large next...
View ArticleRosetta Genomics to Increase the Number of U.S. Sales Territories (Rosetta...
(Source: Rosetta Genomics Ltd) PHILADELPHIAand REHOVOT, Israel, June 4, 2013/PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular...
View ArticlebioTheranostics to Present Data on CancerTYPE ID and Breast Cancer Index at...
Data from 11 studies demonstrate the clinical utility and cost-effectiveness of company’s molecular tests for cancer of unknown primary and breast cancer recurrence 2013 ASCO Annual Meeting SAN...
View ArticleGenomic Health Announces Ten Studies Covering Breast, Colon and Prostate...
(Source: Genomic Health Inc) REDWOOD CITY, Calif., May 21, 2013/PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that results from ten studies in breast, colon and prostate cancer,...
View ArticleGenomic Health Announces Ten Studies Covering Breast, Colon and Prostate...
My news for Investors AtLeast one of the check box should be selected You are following news about Follow the latest news about GHDX Download image REDWOOD CITY, Calif., May 21, 2013 /PRNewswire/ --...
View ArticleAtossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the 2013 ASCO...
http://media.marketwire.com/attachments/201305/61335_atossa.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1020106&ProfileId=051205&sourceType=1 SEATTLE, WA --...
View ArticleRosetta Genomics to Increase the Number of U.S. Sales Territories
PHILADELPHIA and REHOVOT, Israel, June 4, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces plans to expand its...
View ArticleMyriad Genetics to Present PROLARIS(R) Data at ASCO 2013, Continuing Its...
SALT LAKE CITY, May 30, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that Jack Cuzick, Ph.D., of Queen Mary College University of London, will present data from five...
View ArticleAtossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the 2013 ASCO...
(Source: Atossa Genetics Inc) Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the 2013 ASCO Annual Meeting SEATTLE, WA -- (Marketwired) -- 05/23/13 -- Atossa Genetics, Inc. (NASDAQ:...
View ArticleMyriad Genetics to Present PROLARIS(R) Data at ASCO 2013, Continuing Its...
(Source: Myriad Genetics Inc) SALT LAKE CITY, May 30, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that Jack Cuzick, Ph.D., of Queen Mary College University of London,...
View ArticleRosetta Genomics Announces Presence at ASCO 2013
PHILADELPHIA and REHOVOT, Israel, May 28, 2013 /PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the...
View ArticleRosetta Genomics Announces Presence at ASCO 2013 (Rosetta Genomics Ltd)
(Source: Rosetta Genomics Ltd) PHILADELPHIAand REHOVOT, Israel, May 28, 2013/PRNewswire/ -- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular...
View ArticleMayo Clinic Forms Joint Venture with Cancer Genetics
OncoSpire Genomics will seek to discover and commercialize biomarkers for multiple cancer types RUTHERFORD, N.J.--(BUSINESS WIRE)--Mayo Clinic ("Mayo") and Cancer Genetics Inc. (OTCQB: CGIX) today...
View ArticleCancer Genetics to Present at Marcum MicroCap Conference
Marcum MicroCap Conference 2013 RUTHERFORD, N.J.--(BUSINESS WIRE)--Cancer Genetics, Inc. (OTCQB: CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based cancer diagnostics, will present at the...
View Article
